Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
GE Group
GE Group
Activities:
Analysis
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery
The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
ISPE announces 2024 Facility of the Year Awards category winners
The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Manufacturing
Chime Biologics announces $190m funds to accelerate capacity expansion
The China-based CDMO has plans to increase the total manufacturing capacity to more than 140,000 L within the next 5 years
Ingredients
GE Healthcare collaborates to develop ligands for AAV purification
Australian Children’s Medical Research Institute and GE have agreed to develop new affinity ligands for the purification of adeno-associated viral (AAV) vectors used in gene therapies
Manufacturing
GE Healthcare Life Sciences launches software for cell therapy workflow
The SpinOculation C-Pro Protocol software closes and automates the cell transduction step
Research & Development
New Harvard consortium focuses on advanced bioproduction
The overarching mission of the collaboration is to catalyse the development of transformative therapies by shortening the path between research and clinical application
Manufacturing
GE Healthcare launches new KUBio box for viral vector manufacturing
KUBio box is the latest addition to the KUBio modular bioprocessing portfolio
Ingredients
Research partnership removes bottleneck from AAV development
CPI, Cobra Biologics and GE Healthcare Life Sciences have developed a scalable, cost-effective purification process for adeno-associated viruses
Design & Build
GE Healthcare and Germfree working on modular bioprocessing solution
The project is a rapidly deployable process-ready cleanroom and bioprocessing platforms for biotherapeutics such as gene therapy
Subscribe now